Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshtead Group Share News (AHT)

Share Price Information for Ashtead Group (AHT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5,282.00
Bid: 5,284.00
Ask: 5,288.00
Change: 28.00 (0.53%)
Spread: 4.00 (0.076%)
Open: 5,284.00
High: 5,316.00
Low: 5,226.00
Prev. Close: 5,254.00
AHT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Telecom Plus Up On Strong Earnings, Outlook

Tue, 18th Jun 2019 10:23

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------Ashtead, up 3.7%. The equipment rentals firm reported strong annual results in financial 2019 buoyed by its Sunbelt business in the US. For the year to April 30, Ashtead recorded pretax profit of GBP1.06 billion, up 23% from GBP862.1 million the year before, as revenue increased 19% to GBP4.50 billion. Its Sunbelt unit saw US total revenue, including new and used equipment, merchandise and consumable sales, increase 20% to USD4.98 billion from USD4.15 billion. The company benefited from Brexit-driven weakness in the pound, which helped increase the value of dollar revenue from the US. Ashtead proposed a final dividend of 33.5 pence, bringing a total payout 40.0 pence, up 21% from 33.0p in financial 2018. The firm added that it continues to look to the medium term with confidence and expects to return up to GBP500 million via share buybacks in 2020 financial year. "This business has been in a sweet spot for a long time thanks to a vibrant US construction market and a structural shift from owning to renting equipment," said AJ Bell's Russ Mould. ----------AstraZeneca, up 1.5%. The Anglo-Swedish drugmaker said Lynparza has been approved in Europe as a first-line maintenance treatment for BRCA-mutated advanced ovarian cancer. The European Commission approved the drug for adults patients with stage three and four ovarian cancer who have a BRCA mutation. BRCA1 and BRCA2 genes help suppress the growth of tumours, and mutations in these genes is associated with an increased risk of cancer. The approval covers "high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer" patients who have responded to 1st-line platinum-based chemotherapy. Lynparza is the only PARP inhibitor approved in the EU for this indication. PARP is an enzyme in cells that helps to repair damaged DNA, and so inhibiting this enzyme prevents cancer cells from repairing themselves.----------FTSE 100 - LOSERS----------Evraz, down 1.5%. The Russian steelmaker was cut to Sell from Neutral by Citigroup.----------InterContinental Hotels Group, down 1.2%. Barclays downgraded the hotel operator to Underweight from Equal Weight. ----------FTSE 250 - WINNERS----------Telecom Plus, up 4.5%. The multi utility services provider said it delivered annual results for financial 2019 in line with expectations. For the year ended March 31, revenue rose 1.5% to GBP804.4 million from GBP792.9 million the year before, and pretax profit increased 4.9% to GBP43.0 million from GBP41.0 million. Adjusted pretax profit increased by 3.7% to GBP56.3 million from GBP54.3 million in 2018. The company said that in the absence of "unforeseen circumstances" it expect adjusted pretax profit for financial 2020 to be between GBP60 million and GBP65 million. Telecom Plus raised its annual dividend 4.0% to 52.0p from 50.0p last year and expects to raise its payout another 10% to 57p in financial 2020. ----------Acacia Mining, up 2.0%. Berenberg raised the gold miner to Hold from Sell. ----------FTSE 250 - LOSERS----------Safestore Holdings, down 1.5%. The self storage company reported a sharp drop in profit in the first half of its financial year due to a considerable reduction in its gain on investment properties. The company company reported a GBP38.2 million pretax profit for the six months to April 30, 53% below its GBP81.9 million profit a year before. This was due to reduced gain on investment properties, coming in at GBP7.9 million for the half compared to a much larger GBP51.8 million gain the year before. On an underlying basis, which excludes investment property gains and other factors, pretax profit rose 7.1% to GBP31.5 million from GBP29.4 million. Revenue rose 5.6% to GBP73.1 million from GBP69.2 million and the company increased its dividend by 7.8% to 5.5 pence from 5.1p.----------OTHER MAIN MARKET AND AIM - WINNERS----------Team17 Group, up 17%. The video game developer said it expects revenue and earnings for 2019 to be ahead of market expectations. Team17 said that both revenue and adjusted earnings before interest, taxes, depreciation and amortisation are set to be ahead of market expectations for the year. In 2018, Team 17 reported adjusted Ebitda of GBP15.3 million on revenue of GBP43.2 million. Since the start of the year, the company said it has continued to experience strong customer traction from both new and established games. Specifically, for the first six months to the end of June, Team17's performance was driven by continued sales momentum, and a solid performances across a range of new releases as well as the recognition of a higher proportion of revenue, which is related to license income.----------OTHER MAIN MARKET AND AIM - LOSERS----------Regency Mines, down 17%. Shares in the natural resource exploration company were down after White Car, in which Regency's subsidiary EsTeq is invested, announced it entered voluntary liquidation. White Car operates Tesla rental car services out of Heathrow and several UK locations. In December 2017, Regency Mines said that EsTeq had invested GB200,000 in White Car, and that it planned to make a further GBP200,000 investment in February 2018, which would give EsTeq a 5.8% stake. EsTeq's investment in White Car was held at no value in Regency's most recent interim accounts for the period to the end of December, published on March 29. Regency said that it is continuing a strategic review of its operations, alongside the formation of a revised board of directors.----------

More News
12 May 2021 08:11

LONDON BRIEFING: UDG Healthcare accepts GBP2.6 billion takeover offer

LONDON BRIEFING: UDG Healthcare accepts GBP2.6 billion takeover offer

Read more
11 May 2021 13:31

Tuesday broker round-up

(Sharecast News) - Safestore: Liberum upgrades to buy with a target price of 1,060p.

Read more
11 May 2021 09:43

BROKER RATINGS: Vodafone on Goldman Sachs' Conviction Buy List

BROKER RATINGS: Vodafone on Goldman Sachs' Conviction Buy List

Read more
4 May 2021 12:51

Berenberg hikes target price on Ashtead

(Sharecast News) - Analysts at Berenberg significantly raised their target price on building equipment provider Ashtead from 2,850.0p to 4,850.0p on Tuesday, citing the group's "ambitious" market share plans.

Read more
4 May 2021 09:40

BROKER RATINGS: JPMorgan and Morgan Stanley differ on Trustpilot

BROKER RATINGS: JPMorgan and Morgan Stanley differ on Trustpilot

Read more
22 Apr 2021 09:41

BROKER RATINGS: JPMorgan cuts Synthomer to neutral from overweight

BROKER RATINGS: JPMorgan cuts Synthomer to neutral from overweight

Read more
21 Apr 2021 09:42

BROKER RATINGS: Deutsche Bank starts coverage on BP and Shell at buy

BROKER RATINGS: Deutsche Bank starts coverage on BP and Shell at buy

Read more
20 Apr 2021 12:53

Ashtead to resume share buyback as annual results to beat expectations

Ashtead to resume share buyback as annual results to beat expectations

Read more
14 Apr 2021 09:38

BROKER RATINGS: UBS says buy FirstGroup, National Express, Stagecoach

BROKER RATINGS: UBS says buy FirstGroup, National Express, Stagecoach

Read more
1 Apr 2021 12:23

LONDON MARKET MIDDAY: FTSE 100 rises as retailers rally on Next update

LONDON MARKET MIDDAY: FTSE 100 rises as retailers rally on Next update

Read more
1 Apr 2021 09:35

BROKER RATINGS: Davy starts Rentokil and Bunzl with Outperform

BROKER RATINGS: Davy starts Rentokil and Bunzl with Outperform

Read more
1 Apr 2021 09:21

UPDATE 2-London stocks end higher on optimism over swift economic recovery

(There will be no London stock market report on Friday and Monday on account of Easter holidays. Reuters will resume coverage on Tuesday, April 6)* Industrials stocks biggest gainers on FTSE 100* Quilter rises on sale of int'l business to Utmost Gr...

Read more
30 Mar 2021 13:16

Tuesday broker round-up

(Sharecast News) - Fevertree: RBC Capital Markets downgrades to sector perform with a target price of 2,000p.

Read more
15 Mar 2021 14:06

Monday broker round-up

(Sharecast News) - Moonpig Group: Citigroup initiates at buy with a target price of 550p.

Read more
15 Mar 2021 10:58

RBC Capital raises target price on Ashtead

(Sharecast News) - Analysts at RBC Capital Markets raised their target price on equipment rental firm Ashtead from 3,200.0p to 3,800.0p on Monday following the group's recently published third-quarter earnings report.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.